Literature DB >> 378836

Lipid A and anti-lipid A.

I Mattsby-Baltzer, B Kaijser.   

Abstract

Lipid A in free form, in crude antigen preparations, and on Formalin-treated Escherichia coli and Salmonella minnesota R595 was employed in studies of its antigenic composition, immunogenicity, and availability on gram-negative bacteria. Analyses with immunodiffusion and crossed immunoelectrophoresis of isolated lipid A preparations revealed three components. Inhibition experiments with enzyme-linked immunosorbent assay showed that the lipid A structure was not exposed on the tested smooth or rough E. coli strains or on S. minnesota R595. In crude O antigen preparations from some of the strains, however, lipid A was available for reaction with antibodies. The inaccessibility of lipid A on the bacterial surface may explain the poor protective capacity of anti-lipid A antibodies against bacterial infections. An enzyme-linked immunosorbent assay was more sensitive for measuring anti-lipid A antibody activity than indirect hemolysis or indirect hemagglutination. With an enzyme-linked immunosorbent assay it was shown that in rabbits the immunogenicity of lipid A was approximately the same when coated on erythrocytes or, as is more commonly done, when lipid A-coated hydrolyzed bacteria were used. Some antisera from rabbits immunized with E. coli of different serotypes showed activity against lipid A, with a higher frequency for antisera from rabbits immunized with R mutants.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 378836      PMCID: PMC414231          DOI: 10.1128/iai.23.3.758-763.1979

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  37 in total

1.  A sensitive colorimetric method for the estimation of 2-deoxy sugars with the use of the malonaldehyde-thiobarbituric acid reaction.

Authors:  V S WARAVDEKAR; L D SASLAW
Journal:  J Biol Chem       Date:  1959-08       Impact factor: 5.157

2.  PURIFICATION AND CHARACTERIZATION OF THE LIPID A COMPONENT OF THE LIPOPOLYSACCHARIDES FROM ESCHERICHIA COLI.

Authors:  A J BURTON; H E CARTER
Journal:  Biochemistry       Date:  1964-03       Impact factor: 3.162

3.  STUDIES OF URINARY TRACT INFECTIONS IN INFANCY AND CHILDHOOD. I. ANTIBODY RESPONSE IN DIFFERENT TYPES OF URINARY TRACT INFECTIONS CAUSED BY COLIFORM BACTERIA.

Authors:  J WINBERG; H J ANDERSEN; L A HANSON; K LINCOLN
Journal:  Br Med J       Date:  1963-08-31

4.  [ON THE IMMUNOCHEMISTRY OF SOMATIC ANTIGENS OF ENTEROBACTERIACEAE. IX. SEROLOGICAL TYPING OF SALMONELLA R ANTIGENS].

Authors:  I BECKMANN; O LUEDERITZ; O WESTPHAL
Journal:  Biochem Z       Date:  1964-05-22

5.  ANTIGEN-ANTIBODY CROSSED ELECTROPHORESIS.

Authors:  C B LAURELL
Journal:  Anal Biochem       Date:  1965-02       Impact factor: 3.365

6.  A slide microtechnique for the analysis of immune precipitates in gel.

Authors:  C WADSWORTH
Journal:  Int Arch Allergy Appl Immunol       Date:  1957

7.  Bacterial hemagglutination and hemolysis.

Authors:  E NETER
Journal:  Bacteriol Rev       Date:  1956-09

8.  Immunization with R mutants of Salmonella minnesota. II. Comparison of the protective effect of immunization with lipid A and the Re mutant.

Authors:  S C Bruins; R Stumacher; M A Johns; W R McCabe
Journal:  Infect Immun       Date:  1977-07       Impact factor: 3.441

9.  Immunization with R mutants of Salmonella minnesota. II. Serological response to lipid A and the lipopolysaccharide of Re mutants.

Authors:  M A Johns; S C Bruins; W R McCabe
Journal:  Infect Immun       Date:  1977-07       Impact factor: 3.441

10.  Relation of structure to function in bacterial O antigens. II. Fractionation of lipids present in Boivin-type endotoxin of Serratia marcescens.

Authors:  A NOWOTNY
Journal:  J Bacteriol       Date:  1963-02       Impact factor: 3.490

View more
  20 in total

1.  ELISA for antibodies to lipid A, lipopolysaccharides and other hydrophobic antigens.

Authors:  M A Freudenberg; A Fomsgaard; I Mitov; C Galanos
Journal:  Infection       Date:  1989 Sep-Oct       Impact factor: 3.553

2.  Specific detection of Haemophilus influenzae type b lipooligosaccharide by immunoassay.

Authors:  J Mertsola; R S Munford; O Ramilo; X Sáez-Llorens; M M Mustafa; G H McCracken; E J Hansen
Journal:  J Clin Microbiol       Date:  1990-12       Impact factor: 5.948

Review 3.  Immunotherapeutic advances in the treatment of gram-negative bacterial sepsis.

Authors:  D L Dunn
Journal:  World J Surg       Date:  1987-04       Impact factor: 3.352

4.  Antibiotics enhance binding by human lipid A-reactive monoclonal antibody HA-1A to smooth gram-negative bacteria.

Authors:  S A Siegel; M E Evans; M Pollack; A O Leone; C S Kinney; S H Tam; P E Daddona
Journal:  Infect Immun       Date:  1993-02       Impact factor: 3.441

5.  [Immunopathology of pyelonephritis].

Authors:  K Rother
Journal:  Klin Wochenschr       Date:  1983-10-17

6.  Experimental Escherichia coli ascending pyelonephritis in rats: changes in bacterial properties and the immune response to surface antigens.

Authors:  I Mattsby-Baltzer; L A Hanson; B Kaijser; P Larsson; S Olling; C Svanborg-Edén
Journal:  Infect Immun       Date:  1982-02       Impact factor: 3.441

7.  Experimental Escherichia coli ascending pyelonephritis in rats: active peroral immunization with live Escherichia coli.

Authors:  I Mattsby-Baltzer; L A Hanson; S Olling; B Kaijser
Journal:  Infect Immun       Date:  1982-02       Impact factor: 3.441

8.  The importance of anti-lipid A (anti-endotoxin): prevention of "shock lung" and acute renal failure.

Authors:  E N Wardle
Journal:  World J Surg       Date:  1982-09       Impact factor: 3.352

9.  Antigenic heterogeneity of lipid A of Haemophilus influenzae.

Authors:  M A Apicella; K C Dudas; A Campagnari; P Rice; J M Mylotte; T F Murphy
Journal:  Infect Immun       Date:  1985-10       Impact factor: 3.441

10.  Lipid A in anaerobic bacteria.

Authors:  G Dahlén; I Mattsby-Baltzer
Journal:  Infect Immun       Date:  1983-01       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.